Selectis Health Appoints Two Experienced Directors, Including Former CEO, to Board
summarizeSummary
Selectis Health, Inc. has appointed Kent Lund and Lance Baller to its Board of Directors, bringing significant legal, financial, and prior company leadership experience to the micro-cap firm.
check_boxKey Events
-
New Board Appointments
Effective January 1, 2026, Kent Lund and Lance Baller were appointed to the Board of Directors of Selectis Health, Inc.
-
Experienced Legal and Securities Professional Joins Board
Kent Lund, age 70, brings extensive experience in business, legal, and securities, including serving on the Colorado Securities Board and FINRA West Region Committee.
-
Former CEO Returns to Board
Lance Baller, age 51, a co-founder of Iofina Plc and former CEO/Director of Selectis Health from 2015 to 2023, adds deep expertise in corporate finance, capital markets, and mergers and acquisitions.
auto_awesomeAnalysis
The addition of Mr. Lund and Mr. Baller significantly strengthens Selectis Health's Board of Directors. Mr. Lund's extensive background in business, legal, and securities, including regulatory experience, enhances governance and compliance oversight. Mr. Baller's return to the board, having previously served as CEO and Director, provides invaluable institutional knowledge and expertise in corporate finance, capital markets, and mergers and acquisitions, which is particularly beneficial for a company of this size. These appointments suggest a strategic move to bolster leadership and guide future growth initiatives.
At the time of this filing, GBCS was trading at $2.23 on OTC in the Real Estate & Construction sector, with a market capitalization of approximately $6.8M. The 52-week trading range was $0.41 to $6.99. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.